Medicines A–Z
L
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
|
Liquid paraffin and white soft paraffin 50:50 ointment | ||
|
Liraglutide (Saxenda®) (GLP1s should all be prescribed by brand name) |
The use of Liraglutide for this indication is restricted to prescribing in secondary care by a specialist multidisciplinary Tier 3 weight management service with a commercial agreement in place. Prescribe by brand (Saxenda®) to avoid patients inadvertently receiving a different product licensed for type 2 diabetes. |
|
|
|
Liraglutide (Victoza®) injection (GLP1s should all be prescribed by brand name) |
THIS IS FOR DIABETES ONLY. Prescribe by brand (Victoza®) to avoid patients inadvertently receiving a different product licensed for obesity. 1.8 mg is non-formulary. |
|
|
Lisdexamfetamine |
ESCAs and additional advice in relation to age of patient and CCG |
|
|
|
Lisdexamfetamine#Red |
ESCAs and additional advice in relation to age of patient and CCG |
|
|
|
Lisinopril tablets | ||
|
|
Lithium carbonate M/R tablet (Priadel) |
Specialist initation only, ESCA |
|
|
|
Lithium citrate liquid priadel |
Specialist initiation only, ESCA |
|
|
|
Lixisenatide (Lyxumia®) |
1st line choice GLP1 for co-prescribing with insulin. RICaD. |
|
|
|
Lizinna |
Umbrella service only |
